Shareholders of MDS, parent company of MDS Nordion of Ottawa, have voted to change the company's name to Nordion.
The approval came after the company closed on the sale of its Pharma Services business on March 15 for $45 million to Ricerca Biosciences, which provides early-stage contract research organization services.
The name change reflects the company's new focus on its remaining medical isotopes business, Nordion officials said. The company also is putting the final touches on the move of its corporate headquarters from Toronto to Ottawa.
Related Reading
MDS inks deals to sell Pharma Services units, February 12, 2010
MDS names Anderson as chairman, February 2, 2010
MDS to lay off 150 in Toronto, February 1, 2010
MDS blames isotope shortage for poor Q4, January 22, 2010
MDS finalizes CEO position, January 8, 2010
Copyright © 2010 AuntMinnie.com
